Loading...

EDSA EDESA BIOTECH INC Investments/Divestments 8-K Filing

DS B

DS

EDESA BIOTECH INC

(EDSA)

2024 8-K

Show Summary

Summary

Equity Offerings

Financial Statements

Management Changes

Financial Results

Financial Results

Capital Structure Change

Share Offering Agreement

Earnings Release

Drug Candidate Selected for...

Annual Meeting Approval

Earnings Release

Earnings Release

Earnings Release

Compliance with Minimum Bid...

Credit Agreement with Parde...

Agreement with Government o...

Default in Payments

Earnings Release

Appointment of CFO

Notice of Delisting

Departure of Directors or C...

Earnings Release

Equity Distribution Agreement

FDIC Control of Silicon Val...

Earnings Release

External Links:

Edesa Biotech announced that its drug candidate, paridiprubart (EB05), has been selected for evaluation in a U.S. government-funded clinical study by BARDA.

AI Assistant

EDESA BIOTECH INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.